|
May 19
|
ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177
|
|
May 7
|
Radiopharm Theranostics to Participate in the D. Boral Capital Inaugural Global Conference
|
|
Apr 28
|
Radiopharm Theranostics Doses First Patient with 18F-RAD101 in U.S. Phase 2b Imaging Study of Brain Metastasis
|
|
Dec 30
|
Radiopharm Announces Strategic Co-Development Partnership with Lantheus for Australia
|
|
Jun 21
|
Radiopharm Receives Strategic Investment for up to A$18 million
|